While increased ROS levels have been reported in tissues from individuals with BTHS and cell models [12], previous studies, including ours, showed unchanged ROS levels in Taz-KD mouse hearts due to enhanced antioxidant defences [9, 32]. This evidence concerns the gene TAFAZZIN and Barth syndrome.